HB4650 Summary

• Amends the Illinois Controlled Substances Act to modify the Prescription Monitoring Program (PMP) for Schedule II, III, IV, and V controlled substances.

• Requires dispensers to transmit detailed prescription data to the central repository within one business day, including recipient information, drug details, prescriber/dispenser DEA registration numbers, and payment type.

• Imposes civil fines up to $100 per day for willful failure to report controlled substance dispensing to the PMP.

• Requires the Department to adopt rules by January 1, 2021 mandating Electronic Health Records Systems to interface with the PMP and establishing pharmacy record integration for faster information transmission.

• Authorizes licensed prescribers and pharmacists (including clinical pharmacists employed by Medicaid Managed Care Organizations) to designate designees to consult the PMP on their behalf under rules established by the Department.